1. Home
  2. PLX vs TDUP Comparison

PLX vs TDUP Comparison

Compare PLX & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLX
  • TDUP
  • Stock Information
  • Founded
  • PLX 1993
  • TDUP 2009
  • Country
  • PLX Israel
  • TDUP United States
  • Employees
  • PLX N/A
  • TDUP N/A
  • Industry
  • PLX Biotechnology: Biological Products (No Diagnostic Substances)
  • TDUP Catalog/Specialty Distribution
  • Sector
  • PLX Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • PLX Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • PLX 160.2M
  • TDUP 172.9M
  • IPO Year
  • PLX 1998
  • TDUP 2021
  • Fundamental
  • Price
  • PLX $2.33
  • TDUP $2.26
  • Analyst Decision
  • PLX
  • TDUP Buy
  • Analyst Count
  • PLX 0
  • TDUP 5
  • Target Price
  • PLX N/A
  • TDUP $3.50
  • AVG Volume (30 Days)
  • PLX 553.9K
  • TDUP 1.3M
  • Earning Date
  • PLX 03-13-2025
  • TDUP 03-03-2025
  • Dividend Yield
  • PLX N/A
  • TDUP N/A
  • EPS Growth
  • PLX N/A
  • TDUP N/A
  • EPS
  • PLX N/A
  • TDUP N/A
  • Revenue
  • PLX $45,667,000.00
  • TDUP $313,757,000.00
  • Revenue This Year
  • PLX N/A
  • TDUP N/A
  • Revenue Next Year
  • PLX $90.00
  • TDUP N/A
  • P/E Ratio
  • PLX N/A
  • TDUP N/A
  • Revenue Growth
  • PLX N/A
  • TDUP 0.58
  • 52 Week Low
  • PLX $0.82
  • TDUP $0.50
  • 52 Week High
  • PLX $2.36
  • TDUP $2.45
  • Technical
  • Relative Strength Index (RSI)
  • PLX 78.72
  • TDUP 71.74
  • Support Level
  • PLX $2.11
  • TDUP $1.21
  • Resistance Level
  • PLX $2.36
  • TDUP $2.45
  • Average True Range (ATR)
  • PLX 0.12
  • TDUP 0.21
  • MACD
  • PLX 0.00
  • TDUP 0.09
  • Stochastic Oscillator
  • PLX 94.23
  • TDUP 84.68

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: